ConductScience.org, home

Paper36920188

In Vitro and In Vivo Efficacy of NITD-916 against Mycobacterium fortuitum.

Roquet-Banères F and 5 others. Antimicrob Agents Chemother, 2023. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. In Vitro and In Vivo Efficacy of NITD-916 against Mycobacterium fortuitum. Papers, record 36920188. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36920188

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In Vitro and In Vivo Efficacy of NITD-916 against Mycobacterium fortuitum.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.99
iCite
Revised in PubMed
2024-09-17
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roquet-Banères FFrançoise
2Alcaraz MMatthéo
3Hamela CClaire
4Abendroth JJan
5Edwards TEThomas E
6Kremer LLaurenthttps://orcid.org/0000-0002-6604-4458

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mycobacterium fortuitumMajor topic
Mycobacterium tuberculosisMajor topic
Animals
Zebrafish
Mycolic Acids
Oxidoreductases

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HHSN272201700059CNIAID NIH HHSUnited StatesPubMed

Source PubMed

Download CSV of grants

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134392175Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery.Bioorg Chem2021https://conductscience.org/library/papers/34392175PubMed
232417538Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.Eur J Med Chem2020https://conductscience.org/library/papers/32417538PubMed
317555433The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development.Mol Microbiol2007https://conductscience.org/library/papers/17555433PubMed
424374164Mycolic acids: structures, biosynthesis, and beyond.Chem Biol2014https://conductscience.org/library/papers/24374164PubMed
530429139Cutaneous Mycobacterial Infections.Clin Microbiol Rev2018https://conductscience.org/library/papers/30429139PubMed
69328647The envelope layers of mycobacteria with reference to their pathogenicity.Adv Microb Physiol1998https://conductscience.org/library/papers/9328647PubMed
728084211Rapidly Growing Mycobacteria.Microbiol Spectr2017https://conductscience.org/library/papers/28084211PubMed
828807917Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28807917PubMed
931860799Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus.ACS Infect Dis2020https://conductscience.org/library/papers/31860799PubMed
1030687747In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics.Biomed Res Int2018https://conductscience.org/library/papers/30687747PubMed
1126104214The Molecular Genetics of Mycolic Acid Biosynthesis.Microbiol Spectr2014https://conductscience.org/library/papers/26104214PubMed
1226382225Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos.J Vis Exp2015https://conductscience.org/library/papers/26382225PubMed
1317220416EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17220416PubMed
1432906655Mycobacteriosis and Infections with Non-tuberculous Mycobacteria in Aquatic Organisms: A Review.Microorganisms2020https://conductscience.org/library/papers/32906655PubMed
1533920196Gene Sequencing and Phylogenetic Analysis: Powerful Tools for an Improved Diagnosis of Fish Mycobacteriosis Caused by Mycobacterium fortuitum Group Members.Microorganisms2021https://conductscience.org/library/papers/33920196PubMed
1637619220Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids.PLoS Pathog2023https://conductscience.org/library/papers/37619220PubMed
1731768399The Integrated Resource for Reproducibility in Macromolecular Crystallography: Experiences of the first four years.Struct Dyn2019https://conductscience.org/library/papers/31768399PubMed
1825568071Direct inhibitors of InhA are active against Mycobacterium tuberculosis.Sci Transl Med2015https://conductscience.org/library/papers/25568071PubMed
1910716087Mycobacterium fortuitum osteomyelitis in a peripheral blood stem cell transplant recipient.Scand J Infect Dis2000https://conductscience.org/library/papers/10716087PubMed
208284673inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.Science1994https://conductscience.org/library/papers/8284673PubMed

See all 54 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
41683947Phagocytosis of Mycobacterium fortuitum by Caprine Alveolar Macrophages Is Associated with iNOS and Pro-Inflammatory Markers Expression.Int J Mol Sci2026https://conductscience.org/library/papers/41683947PubMed
41142442Advancements in laboratory diagnostics for HIV/MTB coinfection: Integrating conventional methods with emerging technologies.Pract Lab Med2025https://conductscience.org/library/papers/41142442PubMed
40635565An alveolus lung-on-a-chip model of Mycobacterium fortuitum lung infection.Dis Model Mech2025https://conductscience.org/library/papers/40635565PubMed
39329871Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches.Diseases2024https://conductscience.org/library/papers/39329871PubMed
37314394New therapeutic strategies for Mycobacterium abscessus pulmonary diseases - untapping the mycolic acid pathway.Expert Rev Anti Infect Ther2023https://conductscience.org/library/papers/37314394PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36920188

GET https://conductscience.org/api/papers/v1/36920188/references?page=2